References
- Tilly H, Gomes da Silva M, Vitolo U, Jack A, Meignan M, Lopez-Guillermo A, et al. Diffuse large B-cell lymphoma (DLBCL): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2015; 26(Suppl 5): v116-25. doi: 10.1093/annonc/mdv304
- Fisher RI, Miller TP, O’Connor OA. Diffuse aggressive lymphoma. Hematology Am Soc Hematol Educ Program 2004; 221-36. doi: 10.1182/asheducation-2004.1.221
- Bush RS, Gospodarowicz M, Sturgeon J, Alison R. Radiation therapy of localized non-Hodgkin’s lymphoma. Cancer Treat Rep 1977; 61: 1129-36. PMID: 332347
- Haque W, Dabaja B, Tann A, Khan M, Szeja S, Butler EB, et al. Changes in treatment patterns and impact of radiotherapy for early stage diffuse large B cell lymphoma after rituximab: a population-based analysis. Radiother Oncol 2016; 120: 150-5. doi: 10.1016/j.radonc.2016.05.027
- Vargo JA, Gill BS, Balasubramani GK, Beriwal S. Treatment selection and survival outcomes in early-stage diffuse large B-cell lymphoma: do we still need consolidative radiotherapy? J Clin Oncol 2015; 33: 3710-7. doi: 10.1200/JCO.2015.61.7654
- Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R, et al. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 2002; 346: 235-42. doi: 10.1056/NEJMoa011795
- Pfreundschuh M, Kuhnt E, Trumper L, Osterborg A, Trneny M, Shepherd L, et al. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol 2011; 12: 1013-22. doi: 10.1016/S1470-2045(11)70235-2
- Phan J, Mazloom A, Medeiros LJ, Zreik TG, Wogan C, Shihadeh F, et al. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol 2010; 28: 4170-6. doi: 10.1200/JCO.2009.27.3441
- Held G, Murawski N, Ziepert M, Fleckenstein J, Poschel V, Zwick C, et al. Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol 2014; 32: 1112-8. doi: 10.1200/JCO.2013.51.4505
- Chapuy B, Stewart C, Dunford AJ, Kim J, Kamburov A, Redd RA, et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat Med 2018; 24: 679-90. doi: 10.1038/s41591-018-0016-8
- Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503-11. doi: 10.1038/35000501
- Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275-82. doi: 10.1182/blood-2003-05-1545
- Lenz G, Wright G, Dave SS, Xiao W, Powell J, Zhao H, et al. Stromal gene signatures in large-B-cell lymphomas. N Engl J Med 2008; 359: 2313-23. doi: 10.1056/NEJMoa0802885
- Chong VC, Yap ES, Xin L, Chin ST, Jeyasekharan A, Chee Y-L, et al. Immunophenotypic and genetic characteristics of diffuse large B-cell lymphoma (DLBCL), and prognostic significance of cell of origin (COO) in a southeast Asian cohort. Blood 2018; 132(Suppl 1): 4222. doi: 10.1182/blood-2018-99-119672
- International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin’s lymphoma. N Engl J Med 1993; 329: 987-94. doi: 10.1056/NEJM199309303291402
- Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014; 32: 3059-68. doi: 10.1200/JCO.2013.54.8800
- Yahalom J, Mauch P. The involved field is back: issues in delineating the radiation field in Hodgkin’s disease. Ann Oncol 2002; 13(Suppl 1): 79-83. doi: 10.1093/annonc/13.s1.79
- Illidge T, Specht L, Yahalom J, Aleman B, Berthelsen AK, Constine L, et al. Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys 2014; 89: 49-58. doi: 10.1016/j. ijrobp.2014.01.006
- Specht L. Does radiation have a role in advanced stage Hodgkin’s or Non-Hodgkin lymphoma? Curr Treat Options Oncol 2016; 17: 4. doi: 10.1007/s11864-015-0377-x
- Horning SJ, Weller E, Kim K, Earle JD, O’Connell MJ, Habermann TM, et al. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin’s lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol 2004; 22: 3032-8. doi: 10.1200/JCO.2004.06.088
- Reyes F, Lepage E, Ganem G, Molina TJ, Brice P, Coiffier B, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med 2005; 352: 1197-205. doi: 10.1056/NEJMoa042040
- Bonnet C, Fillet G, Mounier N, Ganem G, Molina TJ, Thieblemont C, et al. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol 2007; 25: 787-92. doi: 10.1200/JCO.2006.07.0722
- Aviles A, Nambo MJ, Calva A, Neri N, Cleto S, Silva L. Adjuvant radiotherapy in patients with diffuse large B-cell lymphoma in advanced stage (III/IV) improves the outcome in the rituximab era. Hematology 2018; 1-5. doi: 10.1080/10245332.2018.1423880
- Lamy T, Damaj G, Soubeyran P, Gyan E, Cartron G, Bouabdallah K, et al. R-CHOP 14 with or without radiotherapy in nonbulky limited-stage diffuse large B-cell lymphoma. Blood 2018; 131: 174-81. doi: 10.1182/blood-2017-07-793984
- Pfreundschuh M, Murawski N, Ziepert M, Altmann B, Dreyling MH, Borchmann P, et al. Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA. J Clin Oncol 2018; 36(15 Suppl): 7574. doi: 10.1200/JCO.2018.36.15_suppl.7574.
- Shi Z, Das S, Okwan-Duodu D, Esiashvili N, Flowers C, Chen Z, et al. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. Int J Radiat Oncol Biol Phys 2013; 86: 569-77. doi: 10.1016/j.ijrobp.2013.02.007
- Fridrik MA. ASCO update on lymphoma. Memo 2017; 10: 218-9. doi: 10.1007/s12254-017-0372-y
- Issa DE, van de Schans SA, Chamuleau ME, Karim-Kos HE, Wondergem M, Huijgens PC, et al. Trends in incidence, treatment and survival of aggressive B-cell lymphoma in the Netherlands 1989-2010. Haematologica 2015; 100: 525-33. doi: 10.3324/haematol.2014.107300